TY - JOUR
T1 - Half-Century of Cancer Biomarkers:
T2 - Lessons from the Past and Projections for the Future
AU - Filippou, Panagiota
AU - Diamandis, Eleftherios P.
PY - 2019/10/15
Y1 - 2019/10/15
N2 - A handful of cancer biomarkers are used widely in clinical practice, mainly for aiding in diagnosis and for monitoring therapy. These biomarkers include α-fetoprotein (AFP),4 carcinoembryonic antigen (CEA), prostate-specific antigen, and the carbohydrate antigens CA125, CA19.9, and CA15.3. Other, more specialized cancer biomarkers are used less frequently. Molecular/genomic markers will not be discussed here.
AB - A handful of cancer biomarkers are used widely in clinical practice, mainly for aiding in diagnosis and for monitoring therapy. These biomarkers include α-fetoprotein (AFP),4 carcinoembryonic antigen (CEA), prostate-specific antigen, and the carbohydrate antigens CA125, CA19.9, and CA15.3. Other, more specialized cancer biomarkers are used less frequently. Molecular/genomic markers will not be discussed here.
U2 - 10.1373/jalm.2016.021824
DO - 10.1373/jalm.2016.021824
M3 - Article
SN - 2475-7241
VL - 2
SP - 288
JO - Journal of Applied Laboratory Medicine
JF - Journal of Applied Laboratory Medicine
IS - 2
ER -